Education, International, EUGLOH, Research
SPOC MIRACIP : Management of immunorelated complication of cancer immunotherapy - Spring 2026
… are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … those of traditional cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be … charge for EUGLOH students. However, a fee will apply for professionals. For further information, please contact the …
Published on: